Yoshida Takuya, Kumagai Hiromichi
Department of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, Japan.
Clin Calcium. 2016 Mar;26(3):369-74.
Abnormalities of mineral metabolism develop with decline of renal function in chronic kidney disease (CKD), and it is called as a CKD-mineral and bone disorder (CKD-MBD). The standard approach for management of CKD-MBD is to keep serum phosphorus, calcium, and parathyroid hormone in the reference range by dietary intervention and medications. It has been recently pointed out that starting the treatment from early CKD is important for suppressing CKD-MBD.
矿物质代谢异常在慢性肾脏病（CKD）患者中随着肾功能减退而出现，这被称为CKD-矿物质和骨代谢紊乱（CKD-MBD）。管理CKD-MBD的标准方法是通过饮食干预和药物治疗使血清磷、钙和甲状旁腺激素保持在参考范围内。最近有人指出，从CKD早期开始治疗对于抑制CKD-MBD很重要。
